Publication:
Radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) patients treated with sorafenib monotherapy: real-world treatment patterns and clinical outcomes in Türkiye

Simple item page
dc.contributor.coauthorIpek, S. A.
dc.contributor.coauthorKara, I. O.
dc.contributor.coauthorBayram, E.
dc.contributor.coauthorEryilmaz, M. K.
dc.contributor.coauthorAtes, O.
dc.contributor.coauthorYasar, H. A.
dc.contributor.coauthorEkinci, F.
dc.contributor.coauthorAlan, O.
dc.contributor.coauthorHacibekiroglu, I.
dc.contributor.coauthorSakalar, T.
dc.contributor.coauthorAlkan, S.
dc.contributor.coauthorYurdatap, D.
dc.contributor.coauthorKantar, T. G.
dc.contributor.coauthorAsik, E.
dc.contributor.coauthorJeral, S. N.
dc.contributor.coauthorKoseci, T.
dc.contributor.coauthorSahin, B.
dc.contributor.coauthorYaslikaya, S.
dc.date.accessioned2026-08-14T11:26:20Z
dc.date.issued2025
dc.description.harvestedfromManual
dc.description.indexedbyWOS
dc.description.publisherscopeInternational
dc.description.readpublishN/A
dc.description.sponsoredbyTubitakEuN/A
dc.description.versionPublished Version
dc.identifier.ScopusPercentile98
dc.identifier.ScopusQuartileQ1
dc.identifier.WoSPercentile99,2
dc.identifier.WoSQuartileQ1
dc.identifier.doi10.1016/j.annonc.2025.08.3619
dc.identifier.eissn1569-8041
dc.identifier.embargoN/A
dc.identifier.issn0923-7534
dc.identifier.urihttp://doi.org/10.1016/j.annonc.2025.08.3619
dc.identifier.urihttps://hdl.handle.net/20.500.14288/34596
dc.identifier.volume36
dc.identifier.wos001632146900157
dc.keywordsSorafenib
dc.keywordsThyroid cancer
dc.keywordsTyrosine kinase
dc.keywordsOverall survival
dc.keywordsDisease
dc.keywordsCancer treatment
dc.keywordsCancer
dc.languageeng
dc.publisherElsevier
dc.relation.affiliationKoç University
dc.relation.collectionKoç University Institutional Repository
dc.relation.ispartofAnnals of Oncology
dc.relation.openaccessN/A
dc.rightsN/A
dc.rights.uriN/A
dc.subjectHealth sciences
dc.subjectMedicine
dc.subjectOncology
dc.titleRadioiodine-refractory differentiated thyroid cancer (RAI-R DTC) patients treated with sorafenib monotherapy: real-world treatment patterns and clinical outcomes in Türkiye
dc.typeMeeting Abstract
dspace.entity.typePublication

Files

Collections

Publications without Fulltext